Variant report
Variant | esv3456958 |
---|---|
Chromosome Location | chr2:76772469-76776817 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542166657 | chr2:76772532-76772533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182243269 | chr2:76772540-76772541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141656295 | chr2:76772574-76772575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs147050438 | chr2:76772621-76772622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs57098716 | chr2:76772643-76772644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185482684 | chr2:76772747-76772748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs539830360 | chr2:76772752-76772753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569201428 | chr2:76772758-76772759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190243299 | chr2:76772766-76772767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551617359 | chr2:76772784-76772785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375610884 | chr2:76772800-76772801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573229715 | chr2:76772802-76772803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534255578 | chr2:76772828-76772829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542009002 | chr2:76772855-76772856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555602120 | chr2:76772894-76772895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567426635 | chr2:76772922-76772923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570544523 | chr2:76775801-76775802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187684657 | chr2:76775836-76775837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147702626 | chr2:76775841-76775842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs142411336 | chr2:76775847-76775848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192636509 | chr2:76775856-76775857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112724305 | chr2:76775865-76775866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371239841 | chr2:76775888-76775889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183591138 | chr2:76775897-76775898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556725685 | chr2:76775898-76775899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1915040 | chr2:76775935-76775936 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs186817263 | chr2:76775998-76775999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560746040 | chr2:76776006-76776007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572508351 | chr2:76776013-76776014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192820686 | chr2:76776064-76776065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561242300 | chr2:76776069-76776070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531839822 | chr2:76776071-76776072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549968827 | chr2:76776072-76776073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs565129776 | chr2:76776083-76776084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532184531 | chr2:76776139-76776140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547319918 | chr2:76776173-76776174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565651256 | chr2:76776177-76776178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536110181 | chr2:76776214-76776215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13398031 | chr2:76776249-76776250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371949203 | chr2:76776258-76776259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184795272 | chr2:76776262-76776263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537189271 | chr2:76776335-76776336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558365390 | chr2:76776350-76776351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs150437278 | chr2:76776367-76776368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190097168 | chr2:76776370-76776371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538842803 | chr2:76776428-76776429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554373128 | chr2:76776434-76776435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572799142 | chr2:76776492-76776493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73938459 | chr2:76776498-76776499 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs561279191 | chr2:76776530-76776531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76771000-76772800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
2 | chr2:76771800-76772800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr2:76771800-76773000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr2:76771800-76773000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr2:76772400-76773000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr2:76775800-76776000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr2:76776000-76807000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |